4D Molecular Therapeutics, Inc. (FDMT) Net income 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$140.1MFY2025 · since FY2019: -$49.3M → -$140.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$140.1M | +12.9% |
| FY2024 | -$160.9M | -59.5% |
| FY2023 | -$100.8M | +6.2% |
| FY2022 | -$107.5M | -50.7% |
| FY2021 | -$71.3M | -25.8% |
| FY2020 | -$56.7M | -15.0% |
| FY2019 | -$49.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice